Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.
about
HIV gp120- and methamphetamine-mediated oxidative stress induces astrocyte apoptosis via cytochrome P450 2E1Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice.Methamphetamine alters the normal progression by inducing cell cycle arrest in astrocytesPrepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system.The HIV-1 transgenic rat model of neuroHIV.Microstructural changes to the brain of mice after methamphetamine exposure as identified with diffusion tensor imaging.Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and MiceNeuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity.Locomotor Profiling from Rodents to the Clinic and Back Again.Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.Role of microglia in methamphetamine-induced neurotoxicity.Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K+ current.Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research.MR brain volumetric measurements are predictive of neurobehavioral impairment in the HIV-1 transgenic rat.Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.
P2860
Q24600332-A988BC6D-E0D7-4D2E-A805-DF5D757D5618Q27311532-477441A8-C1F4-446D-9D19-2487EDF0684CQ28395515-D7C4956B-9219-4566-9673-26049BF014C1Q30443006-A54CAA29-6469-42E2-861F-2E6D1205142AQ35207525-9C660149-FA36-4BD6-82ED-4AAAEB522F48Q36578522-52EE7178-CF24-4214-AEC5-5A5F7352E12CQ36797975-9721E8D7-F947-457E-BD2A-18E024A979DDQ36821772-14E33EEF-7B89-4AE9-9D7D-F3EE5E757BD3Q36934422-ECA7F01C-E1D0-45CA-95D8-DC84E010F4D6Q38897374-202C47B4-9E27-4837-9ACD-A2583F9F3E8CQ38916260-3520DA4C-ADFC-4D51-8B31-D63A9510DB24Q39427179-27683C20-57BF-409F-8E1D-A96E118F72CEQ40182580-AACAE626-E20A-4628-920D-7D4BEE2B5F46Q46229748-C1505AEC-6524-4F98-B57F-98EEF5B4E2B6Q47160714-D52B53B3-AF74-41BC-8693-40AF3693A196Q54979705-F195609C-A71E-474D-97B6-B56138FD03A5
P2860
Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.
@ast
Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.
@en
type
label
Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.
@ast
Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.
@en
prefLabel
Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.
@ast
Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.
@en
P2093
P2860
P1476
Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.
@en
P2093
Arpi Minassian
Brook L Henry
Jared W Young
Mahalah Buell
Mark A Geyer
Translational Methamphetamine AIDS Research Center Group
William Perry
P2860
P304
P356
10.1016/J.BBR.2012.08.037
P407
P577
2012-08-31T00:00:00Z